These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 11332778)
41. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
42. Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses. Sima N; Li R; Huang W; Xu M; Beers J; Zou J; Titus S; Ottinger EA; Marugan JJ; Xie X; Zheng W Orphanet J Rare Dis; 2018 Apr; 13(1):54. PubMed ID: 29631617 [TBL] [Abstract][Full Text] [Related]
43. Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain. Fabritius AL; Vesa J; Minye HM; Nakano I; Kornblum H; Peltonen L Exp Mol Pathol; 2014 Dec; 97(3):484-91. PubMed ID: 25303899 [TBL] [Abstract][Full Text] [Related]
44. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Sleat DE; Donnelly RJ; Lackland H; Liu CG; Sohar I; Pullarkat RK; Lobel P Science; 1997 Sep; 277(5333):1802-5. PubMed ID: 9295267 [TBL] [Abstract][Full Text] [Related]
45. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Ezaki J; Kominami E Brain Pathol; 2004 Jan; 14(1):77-85. PubMed ID: 14997940 [TBL] [Abstract][Full Text] [Related]
46. Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs. Lingaas F; Aarskaug T; Sletten M; Bjerkås I; Grimholt U; Moe L; Juneja RK; Wilton AN; Galibert F; Holmes NG; Dolf G Anim Genet; 1998 Oct; 29(5):371-6. PubMed ID: 9800325 [TBL] [Abstract][Full Text] [Related]
47. Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Young EP; Worthington VC; Jackson M; Winchester BG Eur J Paediatr Neurol; 2001; 5 Suppl A():193-6. PubMed ID: 11588996 [TBL] [Abstract][Full Text] [Related]
48. Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 Brenneman DE; Pearce DA; Kovacs A; DeFrees S J Mol Neurosci; 2017 Sep; 63(1):100-114. PubMed ID: 28812237 [TBL] [Abstract][Full Text] [Related]
49. Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500 [TBL] [Abstract][Full Text] [Related]